bioAffinity Technologies, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
bioAffinity Technologies, Inc. (BIAF) reported Adjustments to Additional Paid in Capital, Warrant Issued of $6.75 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-16
- bioAffinity Technologies, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-12-31 was $2.33M.
- bioAffinity Technologies, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $4.42M.
- bioAffinity Technologies, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-09-30 was $165.72K.
- bioAffinity Technologies, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $6.75M.
- bioAffinity Technologies, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $462.34K, a 88.67% decline from fiscal 2021.
- bioAffinity Technologies, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $4.08M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $6.75M derived: sum of 2 quarters · filed 2026-03-16 | $6.75M 10-K · filed 2026-03-16 | |
| 2025-09-30 | $4.42M 10-Q · filed 2025-11-14 | $4.42M 10-Q · filed 2025-11-14 | ||
| 2022-12-31 | $462.34K 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $165.72K 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $217.97K 10-Q · filed 2022-11-14 | |||
| 2021-12-31 | $4.08M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |